Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2010
03/18/2010US20100069354 7-azaindole derivatives and their use in the inhibition of c-jun n-terminal kinase
03/18/2010US20100069353 Inhibitors of hiv replication
03/18/2010US20100069352 5- [4-(azetidin-3-yloxy)-phenyl]-2-phenyl-5h-thiazolo[5,4-c] pyridin-4-one derivatives and their use as mch receptor antagonists
03/18/2010US20100069351 Spiro compound and use thereof
03/18/2010US20100069350 New Pyridine Analogues III
03/18/2010US20100069349 Novel compounds as cannabinoid receptor ligands
03/18/2010US20100069348 Novel compounds as cannabinoid receptor ligands
03/18/2010US20100069347 Heterocyclyl-substituted anti-hypercholesterolemic compounds
03/18/2010US20100069346 New Azetidine Derivatives as Neurokinin Receptor Antagonists for the Treatment of Gastrointestinal Diseases
03/18/2010US20100069345 Lanthanide-porphyrin complexes as anti-tumor agents
03/18/2010US20100069344 Small molecule antagonists of bcl2 family proteins
03/18/2010US20100069343 Methods of predicting steroid responsiveness with Il-1RII
03/18/2010US20100069342 Formoterol/steroid bronchodilating compositions and methods of use thereof
03/18/2010US20100069341 Tetrahydro-pyranopyrazole cannabinoid modulators
03/18/2010US20100069340 Pharmaceutical compositions of an src kinase inhibitor and an aromatase inhibitor
03/18/2010US20100069339 Novel method of treatment of male sub-fertility
03/18/2010US20100069338 Pharmaceutical compositions
03/18/2010US20100069337 Butyrylcholinesterase inhibitors
03/18/2010US20100069336 High penetration prodrug compositions of mustards and mustard-related compounds
03/18/2010US20100069335 Prevention and Treatment of Ophthalmic Complications of Diabetes
03/18/2010US20100069334 Diagnostic method
03/18/2010US20100069333 Alpha-helix mimetics and method relating to the treatment of cancer stem cells
03/18/2010US20100069332 Lipids containing omega-3 and omega-6 fatty acids
03/18/2010US20100069331 Treatment or prevention of cancer and precancerous disorders
03/18/2010US20100069330 Pharmaceutical Compositions and Methods for Preparing and Using Lipophilic Organosulfur Cell Proliferation Inhibitors
03/18/2010US20100069328 Novel ortho-aminoanilides for the treatment of cancer
03/18/2010US20100069327 Nutritional products comprising saccharide oligomers
03/18/2010US20100069326 Combination Therapies to Treat Cardio- and Cerebro-Vascular Disorders
03/18/2010US20100069325 Pharmaceutical composition for treatment of chronic liver diseases and use thereof
03/18/2010US20100069324 Nanoparticle of glucidamin for treating tumor and preparation method thereof
03/18/2010US20100069323 Composition for application to skin or mucosa
03/18/2010US20100069322 Inhibition of cholera toxins by galatooligosaccharides (gos)
03/18/2010US20100069321 Biological Materials and Uses Thereof
03/18/2010US20100069320 Synergism of gos and polyfructose
03/18/2010US20100069319 Mercaptopurine derivatives and uses thereof
03/18/2010US20100069318 Combination of an hdac inhibitor and an antimetabolite
03/18/2010US20100069317 Crystalline nemorubicin hydrochloride
03/18/2010US20100069316 Treatment for multiple myeloma
03/18/2010US20100069315 Method and medicament for treating ocular infections
03/18/2010US20100069313 Novel powders based on vegetation water from olive oil production
03/18/2010US20100069312 Aminoalkyl glucosamine phosphate compounds for treating autoimmune diseases
03/18/2010US20100069311 Medicament comprising a reducing alkyl-sugar monomer for the treatment of inflammatory disorders
03/18/2010US20100069310 1-chloro-4-( beta -D-glucopyranos-1-yl)-2-[4-((1R,2R)-2-hydroxy-cyclopent-1-yloxy)-benzyl]-benzene; metabolic disorders such as diabetes, metabolic acidosis or ketosis, reactive hypoglycaemia, hyperinsulinaemia; sodium-dependent glucose cotransporter SGLT2 inhibitors
03/18/2010US20100069298 Methods for Detecting Overexpression of SPARC and Therapeutic and Diagnostic Methods Relating to Same
03/18/2010US20100069295 Novel poly(ethylene oxide)-block-poly(ester) block copolymers
03/18/2010US20100069291 Combination comprising cndac (2'-cyano-2'-deoxy-n4-palmitoyl-1-beta-d-arabinofuranosyl-cytosine) and a cytotoxic agent
03/18/2010US20100068695 Inhibitor for enzyme having two divalent metal ions as active center
03/18/2010US20100068314 Herbal composition for treating cd33+ acute and chronic myeloid leukemia and a method thereof
03/18/2010US20100068313 Cranberry seed oil extract and compositions containing components thereof
03/18/2010US20100068308 Regulation of GSK-3alpha activity for the treatment or prevention of Alzheimer's disease
03/18/2010US20100068307 Dermatological emulsion and method for the preparation thereof
03/18/2010US20100068303 Treatment of cancer with bio and chemotherapy
03/18/2010US20100068301 Compositions and treatments comprising 5-lipoxygenase-activating protein inhibitors and nitric oxide modulators
03/18/2010US20100068300 Use of l-carnitine for the preparation of a medicament in the form of eye-drops for treating corneal diseases
03/18/2010US20100068294 Method for Preparing Ortho Silicic Acid, Ortho Silicic Acid as Obtained, and its Use
03/18/2010US20100068292 Novel Inhibitors of Arachidonic Acid Formation
03/18/2010US20100068291 Oral Medicament Based on a Proton Pump Inhibitor
03/18/2010US20100068288 Mixtures or organic compounds for the treatment of airway diseases
03/18/2010US20100068286 Drug Loaded Polymeric Nanoparticles and Methods of Making and Using Same
03/18/2010US20100068285 Drug Loaded Polymeric Nanoparticles and Methods of Making and Using Same
03/18/2010US20100068284 Stable Fixed Dose Topical Formulation
03/18/2010US20100068282 Preparation of pharmaceutical compositions
03/18/2010US20100068280 Sustained release pharmaceutical dosage form containing phenylephrine
03/18/2010US20100068276 Multiparticulates of spray-coated drug and polymer on a meltable core
03/18/2010US20100068273 Pharmaceutical formulation, its use, and method for its manufacture
03/18/2010US20100068272 Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors
03/18/2010US20100068270 Bupropion hydrobromide polymorphs
03/18/2010US20100068269 Treatment and prevention of cardiovascular events
03/18/2010US20100068267 Compositions for treating vascular diseases characterized by nitric oxide insufficiency
03/18/2010US20100068265 Gelatin capsules comprising an acid
03/18/2010US20100068263 Method and Compositions for Stimulation of an Immune Response to TRP2 using a Xenogeneic TRP2 Antigen
03/18/2010US20100068262 Method and Compositions for Stimulation of an Immune Response to PSMA using a Xenogeneic PSMA Antigen
03/18/2010US20100068261 Methods and compositions for the production of monoclonal antibodies
03/18/2010US20100068257 Sustained Release of Antiinfectives
03/18/2010US20100068255 liposomes comprising humanized Fab fragment of monoclonal antibody that binds cell surface markers, amphipathic vesicle-forming lipid and polyethylene glycol derivatized lipid, capable of inhibiting growth and proliferation of target cells; HER growth factor receptors
03/18/2010US20100068251 Aqueous Systems For The Preparation Of Lipid Based Pharmaceutical Compounds; Compositions, Methods, And Uses Thereof
03/18/2010US20100068250 Abuse Potential Reduction in Abusable Substance Dosage Form
03/18/2010US20100068249 Abuse-resistant transdermal dosage form
03/18/2010US20100068242 Medical Devices for Localized Drug Delivery
03/18/2010US20100068238 Implantable Medical Devices Comprising a Flavonoid or Derivative Thereof for Prevention of Restenosis
03/18/2010US20100068229 Recombinant antigens of human cytomegalovirus (hcmv)
03/18/2010US20100068226 Polynucleotides and Uses Thereof
03/18/2010US20100068219 Peptides that mimic non-human cross-reactive protective epitopes of the group b meningococcal capsular polysaccharide
03/18/2010US20100068218 Optimized Multi-Epitope Constructs and Uses Thereof
03/18/2010US20100068216 Method and Compositions for Stimulation of an Immune Response to gp100 using a Xenogeneic gp100 Antigen
03/18/2010US20100068214 Identification of Candidate Vaccine Antigens from Dichelobacter Nodosus
03/18/2010US20100068211 Use of antiresorptive compounds to prevent ionizing radiation-induced activation of osteoclasts and resulting bone loss
03/18/2010US20100068207 DDR2 in Cancer Diagnosis, Detection and Treatment
03/18/2010US20100068206 Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of mantle cell lymphomas
03/18/2010US20100068204 4-aryloxyquinolin-2(1h)-ones as mtor kinase and pi3 kinase inhibitors, for use as anti-cancer agents
03/18/2010US20100068203 17-Oxymacbecin Derivatives and Their Use in the Treatment of Cancer and/or B-Cell Malignancies
03/18/2010US20100068201 Compositions and methods for the systemic treatment of arthritis
03/18/2010US20100068200 Methods and Compositions for Inhibiting Atherosclerosis and Vascular Inflammation
03/18/2010US20100068198 Targeting of alpha-1 or alpha-3 subunit of na+, k+-atpase in the treatment of proliferative diseases
03/18/2010US20100068197 Pharmaceutical compounds as inhibitors of cell proliferation and the use thereof
03/18/2010US20100068181 Pyrrolo [3, 2-a] pyridine derivatives for inhibiting ksp kinesin activity
03/18/2010US20100068179 Phosphohalohydrins, Process For The Production Thereof And Use Thereof
03/18/2010US20100068178 Anti-cancer drugs and uses relating thereto for metastatic malignant melanoma and other cancers
03/18/2010US20100068177 Methods of organ regeneration
03/18/2010US20100068176 Hepatitis c virus inhibitors
1 ... 2346 2347 2348 2349 2350 2351 2352 2353 2354 2355 2356 2357 2358 2359 2360 2361 2362 2363 2364 2365 2366 ... 7860